Nature Shared Cell-Free Chromatin Tracing
Nature shared cell-free chromatin tracing for disease origins [https://x.com/i/status/2030965070809756103]. This post drew 13K views and 56 likes.
Cell-free chromatin tracing, or cf-EpiTracing, is a new method that analyzes epigenetic modifications in circulating cell-free DNA to understand disease origins. Cell-free DNA originates from fragmented chromatin released by dying cells. This allows researchers to capture tissue-specific epigenetic modifications through circulating DNA. This technique can distinguish between B cell lymphoma subtypes with high accuracy. It focuses on chromatin states specific to cell types, like CD34-positive progenitor cells and germinal center B cells. In one study, cf-EpiTracing achieved an AUC of 0.823 in subtype classification. Cf-EpiTracing can also differentiate disease stages, reflecting tumor burden. A machine learning model accurately distinguished early-stage, advanced-stage, and healthy individuals with an AUC of 0.942. This shows promise for non-invasive staging and early diagnosis. The method has potential applications beyond lymphomas, in other malignancies and diseases with distinct epigenomic alterations. It could also be used to characterize treatment resistance, cancer subtyping, and disease progression. This advancement marries epigenomic science with machine learning for insights into disease.
